INIBIDORES DE SULFONAMIDA DE ASPARTIL PROTEASE

The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to phar...

Full description

Saved in:
Bibliographic Details
Main Authors ANDREWS, CLARENCE W., III, LOWEN, GREGORY THOMAS, SHERRILL, RONALD GEORGE, SPALTENSTEIN, ANDREW, FURFINE, ERIC STEVEN, HALE, MICHAEL R
Format Patent
LanguagePortuguese
Published 31.05.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods For inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.
Bibliography:Application Number: PT19990928769T